Ibiglustat
CAS: 1401090-53-6
Ref. TM-T4473
| 1mg | 59.00 € | ||
| 2mg | 86.00 € | ||
| 5mg | 157.00 € | ||
| 10mg | 276.00 € | ||
| 25mg | 484.00 € | ||
| 50mg | 704.00 € | ||
| 100mg | 984.00 € | ||
| 500mg | 1,968.00 € | ||
| 1ml*10 (DMSO) | 134.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
Product Information
Name:
Ibiglustat
Synonyms:
- Venglustat, SAR402671, GZ402671
CAS:
Description:
Ibiglustat (GZ402671) is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. Ibiglustat blocks the formation of glucosylceramide (GL-1), a key intermediate in the synthesis of GL-3. Ibiglustat is potentially useful for treating Fabry disease. Fabry disease is a rare lysosomal storage disorder, which results in abnormal tissue deposits of a particular fatty substance called globotriaosylceramide (GL-3 or Gb3) throughout the body.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
389.49
Formula:
C20H24FN3O2S
Purity:
99.14%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T4473 Ibiglustat
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
